Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
Unknown Phase 2 NCT03452111
Study Description
The long term objective is to develop a gel to be used as a male contraceptive.
Study Details
- Registry ID:
- NCT03452111
- Conditions:
- Healthy, Men, Male Contraception
- Phase:
- Phase 2
- Target Enrollment:
- 420 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (21 sites)
-
Spilhaus Clinical Research Site
Harare, Harare, Zimbabwe -
Spilhaus Clinical Research Site
Harare, Zimbabwe -
Kenyatta National Hospital
Nairobi, Kenya -
University of Bologna, Italy
Bologna, Italy -
University of Manchester, UK
Manchester, Greater Manchester, United Kingdom -
University of Manchester, UK
Manchester, United Kingdom -
University of Edinburgh
Edinburgh, United Kingdom -
Karolinska Institutet
Stockholm, Sweden -
Karolinska Institutet
Stockholm, Södermanland And Uppland, Sweden -
Chilean Institute of Reproductive Medicine
Santiago, Santiago Province, Chile -
Centro de Medicina Reproductiva Shady Grove Chile
Santiago, Vitacura, Chile -
Chilean Institute of Reproductive Medicine
Santiago, Chile -
Eastern Virginia Medical School-EVMS Obstetrics & Gynecology
Norfolk, Virginia, United States -
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States -
University of Kansas
Kansas City, Kansas, United States -
Comprehensive Women's Health Center
Denver, Colorado, United States -
University of Utah
Salt Lake City, Utah, United States -
The Lunquist Institute at Harbor-UCLA Medical Center
Torrance, California, United States -
UC Davis Health
Sacramento, California, United States -
Oregon Health & Science University
Portland, Oregon, United States -
University of Washington Medical Center & Health Sciences
Seattle, Washington, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.